|
Maravai Lifesciences Holdings Inc (NASDAQ: MRVI) |
|
MRVI's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-06-14T11:27:06+00:00
Select the Relationship:
|
|
Select the Category:
|
|
MRVI's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025
COMPANY NAME |
MARKET SHARE 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Ending Q4 2024 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE Q4 2024 |
Maravai Lifesciences Holdings Inc |
68.37% |
73.95% |
62.78 % |
56.68 % |
Anaptysbio inc
|
31.63%
|
26.05%
|
37.22%
|
43.32%
|
Gri Bio Inc
|
0.00%
|
0.00%
|
0.00%
|
0.00%
|
SUBTOTAL |
100% |
100% |
100% |
100% |
MRVI's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
Note: Market share is calculated based on total revenue. To get a more accurate picture of Maravai Lifesciences Holdings Inc's market divisions, geographic dispersion, segments, products, and services, visit Maravai Lifesciences Holdings Inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here.
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com